IRIS
SANTAMATO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.715
NA - Nord America 3.301
AS - Asia 1.539
AF - Africa 50
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 19
SA - Sud America 14
Totale 8.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.277
IE - Irlanda 1.218
CN - Cina 968
UA - Ucraina 822
SE - Svezia 484
FR - Francia 421
IT - Italia 278
IN - India 196
TR - Turchia 171
FI - Finlandia 128
GB - Regno Unito 119
DE - Germania 106
PK - Pakistan 47
EG - Egitto 35
JP - Giappone 34
PL - Polonia 30
IR - Iran 24
SG - Singapore 21
BE - Belgio 20
CA - Canada 20
AU - Australia 19
NL - Olanda 18
EU - Europa 17
TH - Thailandia 14
HK - Hong Kong 13
ES - Italia 12
MY - Malesia 12
RU - Federazione Russa 11
LY - Libia 9
RO - Romania 9
GR - Grecia 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
TW - Taiwan 6
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
SI - Slovenia 5
CH - Svizzera 4
CO - Colombia 4
MX - Messico 4
BD - Bangladesh 3
BR - Brasile 3
CL - Cile 3
HU - Ungheria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
IL - Israele 2
KZ - Kazakistan 2
MM - Myanmar 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SM - San Marino 2
TN - Tunisia 2
YE - Yemen 2
AR - Argentina 1
AT - Austria 1
EC - Ecuador 1
KR - Corea 1
MC - Monaco 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
PH - Filippine 1
QA - Qatar 1
SY - Repubblica araba siriana 1
VN - Vietnam 1
Totale 8.662
Salva come PNG Salva come JPEG
Città #
Dublin 1.217
Jacksonville 579
Dearborn 430
Chandler 391
Nyköping 339
Nanjing 275
Wilmington 168
Beijing 142
Ashburn 140
Princeton 135
Nanchang 119
New York 118
San Mateo 94
Ann Arbor 82
Shenyang 56
Hebei 44
Kunming 42
Tianjin 42
Des Moines 41
Helsinki 37
Seattle 36
Boardman 34
Woodbridge 33
Jinan 29
Jiaxing 28
Changsha 27
Ningbo 26
Hangzhou 25
Foggia 24
Pune 24
Bari 22
Zhengzhou 20
Guangzhou 17
Hilden 17
Brussels 16
Los Angeles 15
Kraków 13
Lanzhou 13
Flushing 12
Houston 12
Redwood City 12
Rome 12
Changchun 11
Ismailia 11
Kocaeli 11
Lahore 11
San Francisco 11
Singapore 11
Bengaluru 10
Berlin 10
London 10
Milan 10
Paris 10
San Genesio Ed Uniti 10
Bangkok 9
Giza 9
Istanbul 9
Taizhou 9
Tripoli 9
Faisalabad 8
Athens 7
Lethbridge 7
Norwalk 7
Shanghai 7
Ankara 6
Auburn Hills 6
Fuzhou 6
Hefei 6
Independence 6
Islamabad 6
Saint Petersburg 6
Taipei 6
Al Mansurah 5
Chicago 5
Delhi 5
Duncan 5
Düsseldorf 5
Las Vegas 5
Mountain View 5
New Orleans 5
Oulu 5
Verona 5
Warsaw 5
Washington 5
Ahmedabad 4
Birmingham 4
Bloomington 4
Chennai 4
Florence 4
Gdansk 4
Hyderabad 4
Jakarta 4
Jeddah 4
Kuala Lumpur 4
Naples 4
Nishigaoka 4
Norwich 4
Perth 4
Peshawar 4
Philadelphia 4
Totale 5.337
Salva come PNG Salva come JPEG
Nome #
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial. 431
Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review 156
Approccio clinico e riabilitativo alla sindrome da conflitto subacromiale 148
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial. 124
VALUTAZIONE BAROPODOMETRICA IN PAZIENTI CON MORBO DI PARKINSON IN FASE INIZIALE,CONFRONTO CON GRUPPO DI CONTROLLO E E SUCCESSIVA VALUTAZIONE DOPO TRATTAMENTO RIABILITATIVO 116
The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. 114
L’attività fisica programmata nella prevenzione dei danni secondari nel bambino diabetico” 111
Lifestyle-related factors in predementia and dementia syndromes. 109
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 106
Efficacia comparata tra laser Neodimio YAG e ultrasuoni nel trattamento della sindrome da conflitto sub acromiale 106
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. 106
Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201 104
Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication. 102
Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis 99
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 98
severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica 96
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease. 95
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. 95
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. 92
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 91
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. 86
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. 85
SBOTE study: Extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial 84
Progression to dementia in probable and possible mild cognitive impairment 83
Vascular risk factors, alcohol intake, and cognitive decline 83
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. 83
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 83
Current and emerging treatments for amyotrophic lateral sclerosis. 82
Lifestyle-related factors in predementia and dementia syndromes. 82
Dietary Fatty acids, age-related cognitive decline, and mild cognitive impairment 82
L'ESERCIZIO ISOCINETICO 81
Lipoproteins, vascular-related genetic factors, and human longevity. 80
Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome). 79
Effect of botulinum toxin type A andmodified constraint-induced movement therapy on motor function of upper limb inchildren with obstetrical brachial plexus palsy 79
Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? 78
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 78
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease 77
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. 76
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging 76
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 76
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? 75
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms. 74
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature 74
Anti-β-Amyloid Immunotherapy forAlzheimer's Disease: Focus on Bapineuzumab. 72
Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: manual needle placement evaluated using ultrasonography. 72
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity 72
Higher total cholesterol, cognitive decline, and dementia. 71
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty. 71
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging 70
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial 70
Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review 70
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging 69
Hypertension and mild cognitive impairment subtypes 68
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment 68
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 67
Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study 66
Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms 66
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease 65
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults 65
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? 64
Tau aggregation inhibitors: The future of Alzheimers pharmacotherapy? 64
Possible role of alpha-lipoic acid in the treatment of peripheral nerve injuries. 63
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 63
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 63
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 62
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia? 61
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 61
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 61
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease 61
Safety and efficacy of incobotulinumtoxin A as a potential treatment for poststroke spasticity 61
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. 61
Effectiveness of the Frequency Rhythmic Electrical Modulation System for the Treatment of Chronic and Painful Venous Leg Ulcers in Older Adults. 60
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 60
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 60
The role of the rehabilitation in subjects with Progressive Supranuclear Palsy: a narrative review 60
Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study. 59
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 59
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. 58
Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches 58
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 58
Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report 56
Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study. 55
Does Spasticity Reduction by Botulinum Toxin Type A Improve Upper Limb Functionality in Adult Post-Stroke Patients? A Systematic Review of Relevant Studies. 55
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 55
Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial 55
Post-stroke spasticity as a condition: a new perspective on patient evaluation 55
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 55
Effect of intrathecal baclofen, botulinum toxin type A and arehabilitation programme on locomotor function after spinal cord injury: a casereport. 54
Current epidemiological approaches to the metabolic-cognitive syndrome. 54
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. 54
Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors. 54
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 54
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 54
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 53
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 53
Pulmonary rehabilitation for patients with bronchiectasis: case reports. 51
High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. 51
Intra-articular injection of botulinum toxin type A for shoulder pain in glenohumeral osteoarthritis: A case series summary and review of the literature 51
Postural and balance disorders in patients with Parkinson's disease: A prospective open-label feasibility study with two months of action observation treatment 51
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 51
Totale 7.785
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.534
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019191 0 0 0 0 0 0 0 0 0 13 44 134
2019/20202.004 420 199 142 41 249 278 267 31 149 37 173 18
2020/20211.182 160 6 129 6 175 63 166 151 167 145 2 12
2021/2022682 100 5 32 32 39 6 17 55 99 57 46 194
2022/20233.070 245 100 88 121 104 205 89 284 1.427 99 164 144
2023/2024498 53 25 25 25 61 238 20 41 7 3 0 0
Totale 9.057